Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

Author: Tepedino Michael E.   Heller Warren H.   Usner Dale W.   Brunner Lynne S.   Morris Timothy W.   Haas Wolfgang   Paterno Michael R.   Comstock Timothy L.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.25, Iss.5, 2009-05, pp. : 1159-1169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content